REGEN
LibraryToolsNotesBlogFAQ
Weight Loss

Weight Loss Peptides

GLP-1 and metabolic compounds, graded on the trial evidence behind the weight they actually move.

Weight-loss peptides are the one corner of this field with large, randomised, placebo-controlled human trials behind it. Semaglutide, tirzepatide, and retatrutide all have published phase 3 data with hard body-weight endpoints, which is why they carry the highest grades in this library. Everything else in the category is graded against that bar. Each entry below lists the dose ranges used in the published protocols, the half-life that sets the injection schedule, and links to the trials themselves.

Guides in this category

Weight Loss peptide questions

How many weight loss peptides are there?

This library covers 8 weight loss compounds, each graded from S (regulatory approval) to F (no usable evidence).

Which weight loss peptide has the strongest evidence?

Retatrutide carries the highest research grade in this category at A. An investigational triple GIP/GLP-1/glucagon receptor agonist producing some of the largest average weight reductions reported for a single agent.

What does the research grade mean?

The grade describes how well a compound has been measured in humans, not how well it works. S means regulatory approval; D means animal data only. Popularity and anecdote do not affect it.

Put the whole protocol
in one place.

Looking for a place to manage your protocol?Looking for a trusted peptide tracker?

REGEN is the #1 personalized peptide care app. Track every vial, dose, and biomarker in one place.REGEN is the #1 personalized peptide care app.